Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.

The Journal of general virology - 1 Sept 2018

Coghill Anna E, Hsu Wan-Lun, Yang Qi, Wang Cheng-Ping, Lou Pei-Jen, Yu Kelly J, Yu Guoqin, Diehl Scott R, Chen Chien-Jen, Goldstein Alisa M, Hildesheim Allan

Abstract excerpt

Epstein-Barr virus (EBV) is an obligatory factor in the development of nasopharyngeal carcinoma (NPC), and anti-EBV IgA antibodies are elevated many years prior to the development of NPC. Nearly all adults are infected with EBV, but only a few develop cancer, suggesting that additional co-factors, including genetic susceptibility, must be required for the disease to manifest. Individuals were selected from the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Variation

Share to Herpesvirus 4, Human

Share to Immunoglobulin A

Share to Nasopharyngeal Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 29975184
DOI: 10.1099/jgv.0.001115
PMCID: PMC6230770

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.PMID 29975184Read ↗

Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families.Semantic proximity Read ↗

Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.Semantic proximity Read ↗

Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan.Semantic proximity Read ↗

A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma.Semantic proximity Read ↗

Epstein–Barr Virus Serology as a Potential Screening Marker for Nasopharyngeal Carcinoma among High-Risk Individuals from Multiplex Families in TaiwanSemantic proximity Read ↗

The Role of Epstein-Barr Virus DNA Load and Serology as Screening Tools for Nasopharyngeal Carcinoma.Semantic proximity Read ↗

The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.Semantic proximity Read ↗

Host genetics of Epstein-Barr virus infection, latency and disease.Semantic proximity Read ↗

Meta-analysis of Epstein-Barr virus genomes in Southern Chinese identifies genetic variants and high risk viral lineage associated with nasopharyngeal carcinoma.Semantic proximity Read ↗

A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screeningSemantic proximity Read ↗

Genetic susceptibility to the endemic form of NPC.Semantic proximity Read ↗

Whole-Exome Sequencing Study of Familial Nasopharyngeal Carcinoma and Its Implication for Identifying High-Risk Individuals.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.